Tazorac Generic Name & Formulations
Legal Class
Rx
General Description
Tazarotene 0.05%, 0.1%; gel; crm.
Pharmacological Class
Retinoid.
How Supplied
Gel—30g, 100g; Crm—30g, 60g
Manufacturer
Generic Availability
Gel (YES); Crm 0.1% (YES), 0.05% (NO)
Tazorac Indications
Indications
Mild to moderate facial acne vulgaris (0.1% strength only).
Tazorac Dosage and Administration
Adult
Cleanse and dry skin. Apply thin film of 0.1% strength to lesions on face once daily in the PM. Women of childbearing potential: begin therapy during normal menses.
Children
<12yrs: not established.
Tazorac Contraindications
Contraindications
Pregnancy.
Tazorac Boxed Warnings
Not Applicable
Tazorac Warnings/Precautions
Warnings/Precautions
Embryo-fetal toxicity. Obtain reliable negative pregnancy test within 2wks before starting therapy; use effective contraception during therapy. Do not use on broken, eczematous, or sunburned skin. Sun sensitivity. Avoid eyes, mouth, mucous membranes, sun and UV light; use adequate sun protection. Increased irritation in extreme weather. Discontinue or reduce frequency if excessive irritation occurs. Nursing mothers.
Tazorac Pharmacokinetics
Elimination
Renal, fecal. Half-life: ~18 hours.
Tazorac Interactions
Interactions
Avoid use until the effects of strong topical drying agents have subsided. Caution with other photosensitizers or irritants. Separate use of emollients at least 1hr before Tazorac.
Tazorac Adverse Reactions
Adverse Reactions
Desquamation, burning/stinging, dry skin, erythema, pruritus, worsening of psoriasis, irritation, skin pain; photosensitivity.
Tazorac Clinical Trials
See Literature
Tazorac Note
Not Applicable
Tazorac Patient Counseling
See Literature
Tazorac Generic Name & Formulations
Legal Class
Rx
General Description
Tazarotene 0.05%, 0.1%; gel; crm.
Pharmacological Class
Retinoid.
How Supplied
Gel—30g, 100g; Crm—30g, 60g
Manufacturer
Generic Availability
Gel (YES); Crm 0.1% (YES), 0.05% (NO)
Tazorac Indications
Indications
Plaque psoriasis.
Tazorac Dosage and Administration
Adult
Cleanse and dry skin. Apply thin film to lesions once daily in the PM; for gel, apply to max 20% body surface area. Initiate with 0.05% strength; may increase to 0.1% as tolerated and clinically indicated. Women of childbearing potential: begin therapy during normal menses.
Children
<18yrs: not established.
Tazorac Contraindications
Contraindications
Pregnancy.
Tazorac Boxed Warnings
Not Applicable
Tazorac Warnings/Precautions
Warnings/Precautions
Embryo-fetal toxicity. Obtain reliable negative pregnancy test within 2wks before starting therapy; use effective contraception during therapy. Do not use on broken, eczematous, or sunburned skin. Sun sensitivity. Avoid eyes, mouth, mucous membranes, sun and UV light; use adequate sun protection. Increased irritation in extreme weather. Discontinue or reduce frequency if excessive irritation occurs. Nursing mothers.
Tazorac Pharmacokinetics
Elimination
Renal, fecal. Half-life: ~18 hours.
Tazorac Interactions
Interactions
Avoid use until the effects of strong topical drying agents have subsided. Caution with other photosensitizers or irritants. Separate use of emollients at least 1hr before Tazorac.
Tazorac Adverse Reactions
Adverse Reactions
Desquamation, burning/stinging, dry skin, erythema, pruritus, worsening of psoriasis, irritation, skin pain; photosensitivity.
Tazorac Clinical Trials
See Literature
Tazorac Note
Not Applicable
Tazorac Patient Counseling
See Literature
Images
